Guardant Health Form 144 lists restricted stock lapses and sales

Guardant Health filed a Form 144 disclosing restricted stock lapses and related sales by an individual.

Rhea-AI Filing Summary

Guardant Health filed a Form 144 disclosing restricted stock lapses and related sales by an individual. The filing lists three reported transactions by Musa Tariq on 04/16/2026 (9,840.00), 05/18/2026 (11,131.00), and 06/16/2026 (15,102.00) tied to equity compensation and a restricted stock lapse dated 06/18/2026.

Insights

Compliance Counsel

Form 144 reports restricted stock lapse and three sale-related entries by an individual.

The filing lists a Restricted Stock Lapse dated 06/18/2026 and three reported transactions for Musa Tariq on 04/16/2026, 05/18/2026, and 06/16/2026 with the numeric values shown in the excerpt. These entries are presented under equity compensation.

Cash‑flow treatment and whether proceeds go to the issuer or selling holder are not stated in the provided excerpt. Subsequent filings or broker records would clarify sale mechanics and compliance with resale conditions.

Key Figures

Restricted Stock Lapse: 06/18/2026 Transaction on 04/16/2026: 9,840.00 Transaction on 05/18/2026: 11,131.00 +1 more

4 metrics

Restricted Stock Lapse 06/18/2026 Date of restricted stock lapse shown in filing

Transaction on 04/16/2026 9,840.00 Securities sold during the past 3 months entry for Musa Tariq

Transaction on 05/18/2026 11,131.00 Securities sold during the past 3 months entry for Musa Tariq

Transaction on 06/16/2026 15,102.00 Securities sold during the past 3 months entry for Musa Tariq

Key Terms

Restricted Stock Lapse, Form 144, Equity Compensation

3 terms

Restricted Stock Lapse financial

"Restricted Stock Lapse | Guardant Health, Inc. | 06/18/2026"

Form 144 regulatory

"144: Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Equity Compensation financial

"06/18/2026 | Restricted Stock Lapse | Guardant Health, Inc. | Equity Compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Guardant Health's (GH) Form 144 disclose?

The Form 144 discloses a Restricted Stock Lapse dated 06/18/2026 and three transaction entries by Musa Tariq. It lists amounts of 9,840.00, 11,131.00, and 15,102.00 on respective dates in April–June 2026.

Who is the reporting individual on the Form 144 for GH?

The filing shows Musa Tariq as the reporting individual. The excerpt lists an address for Tariq and three dated transaction lines tied to Guardant Health equity compensation events in 2026.

Are the transactions tied to equity compensation or public sales?

The excerpt labels the activity as Equity Compensation and notes a Restricted Stock Lapse on 06/18/2026. The filing text does not explicitly state the precise resale method or cash‑flow treatment in the provided excerpt.

What dates and amounts are reported on the Form 144 excerpt?

The excerpt lists three dated entries: 04/16/2026 with 9,840.00, 05/18/2026 with 11,131.00, and 06/16/2026 with 15,102.00. These figures are shown under "Securities Sold During The Past 3 Months."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/22/2026 - 04:08 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001968281
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Guardant Health, Inc.
SEC File Number	001-38683
Address of Issuer	3100 HANOVER STREET PALO ALTO CALIFORNIA 94304
Phone	855-698-8887
Name of Person for Whose Account the Securities are To Be Sold	Tariq Musa
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	1951	255893.00	132599929	06/22/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/18/2026	Restricted Stock Lapse	Guardant Health, Inc.			1951	06/18/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Musa Tariq 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	04/16/2026	116	9840.00
Musa Tariq 3100 HANOVER STREET, PALO ALTO CA 94304	Guardant Health, Inc.	05/18/2026	116	11131.00
Musa Tariq 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	06/16/2026	116	15102.00

144: Remarks and Signature

Remarks
Date of Notice	06/22/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/17/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Musa Tariq
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)